Loading…

Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies

A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma w...

Full description

Saved in:
Bibliographic Details
Published in:Biomedical chromatography 2010-11, Vol.24 (11), p.1234-1239
Main Authors: Bhatta, R. S., Kumar, D., Chhonker, Y. S., Saxena, A. K., Jain, G. K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593
cites cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593
container_end_page 1239
container_issue 11
container_start_page 1234
container_title Biomedical chromatography
container_volume 24
creator Bhatta, R. S.
Kumar, D.
Chhonker, Y. S.
Saxena, A. K.
Jain, G. K.
description A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/bmc.1433
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759134789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1399903096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EoktB4gmQb3BJa8exEx_pqhSkXTgE1KNlOxPW1IlD7C3sY_DGOO1STiBZsuT5_M1ofoReUnJGCSnPzWDPaMXYI7SiRMqCNIQ-RitSClmwppYn6FmM3wghUpT1U3RSEsmrkooV-nXhgh61PyRntccDpF3ocAe34MM0wJiwHjt8q73rdHJhxKHHY8jV_J5c2s1hMCH_xfrrArd5moIxhs0Bb9bFtj3ftncGlyLW0-RzlztNCnja6XnQNty4ERZDTPvOQXyOnvTaR3hxvE_Rl3eXn9fvi82nqw_rt5vCMklZoY0RzHJek6Y2wJuyElbITgrDmopqbmQtLavyJioQhAkqm570laD5AHDJTtHre-80h-97iEkNLlrwXo8Q9lHVPLep6mYh3_yXpExKSVhe7l_UziHGGXo1zW7Q80FRopaoVI5KLVFl9NXRujcDdA_gn2wyUNwDP5yHwz9F6mK7PgqPvIsJfj7wer5RomY1V9cfrxSnTXu9KaVq2W9aBasV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399903096</pqid></control><display><type>article</type><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><source>Wiley</source><creator>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</creator><creatorcontrib>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</creatorcontrib><description>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.1433</identifier><identifier>PMID: 20954216</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Animals ; antithrombitic ; Carbolines - blood ; Carbolines - pharmacokinetics ; Chromatography, High Pressure Liquid - methods ; Fibrinolytic Agents - blood ; Fibrinolytic Agents - pharmacokinetics ; LC-MS/MS ; Male ; pharmacokinetics ; preclinical ; Rabbits ; Sulfonamides - blood ; Sulfonamides - pharmacokinetics ; Tandem Mass Spectrometry - methods</subject><ispartof>Biomedical chromatography, 2010-11, Vol.24 (11), p.1234-1239</ispartof><rights>Copyright © 2010 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</citedby><cites>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20954216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhatta, R. S.</creatorcontrib><creatorcontrib>Kumar, D.</creatorcontrib><creatorcontrib>Chhonker, Y. S.</creatorcontrib><creatorcontrib>Saxena, A. K.</creatorcontrib><creatorcontrib>Jain, G. K.</creatorcontrib><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley &amp; Sons, Ltd.</description><subject>Animals</subject><subject>antithrombitic</subject><subject>Carbolines - blood</subject><subject>Carbolines - pharmacokinetics</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Fibrinolytic Agents - blood</subject><subject>Fibrinolytic Agents - pharmacokinetics</subject><subject>LC-MS/MS</subject><subject>Male</subject><subject>pharmacokinetics</subject><subject>preclinical</subject><subject>Rabbits</subject><subject>Sulfonamides - blood</subject><subject>Sulfonamides - pharmacokinetics</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhi0EoktB4gmQb3BJa8exEx_pqhSkXTgE1KNlOxPW1IlD7C3sY_DGOO1STiBZsuT5_M1ofoReUnJGCSnPzWDPaMXYI7SiRMqCNIQ-RitSClmwppYn6FmM3wghUpT1U3RSEsmrkooV-nXhgh61PyRntccDpF3ocAe34MM0wJiwHjt8q73rdHJhxKHHY8jV_J5c2s1hMCH_xfrrArd5moIxhs0Bb9bFtj3ftncGlyLW0-RzlztNCnja6XnQNty4ERZDTPvOQXyOnvTaR3hxvE_Rl3eXn9fvi82nqw_rt5vCMklZoY0RzHJek6Y2wJuyElbITgrDmopqbmQtLavyJioQhAkqm570laD5AHDJTtHre-80h-97iEkNLlrwXo8Q9lHVPLep6mYh3_yXpExKSVhe7l_UziHGGXo1zW7Q80FRopaoVI5KLVFl9NXRujcDdA_gn2wyUNwDP5yHwz9F6mK7PgqPvIsJfj7wer5RomY1V9cfrxSnTXu9KaVq2W9aBasV</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Bhatta, R. S.</creator><creator>Kumar, D.</creator><creator>Chhonker, Y. S.</creator><creator>Saxena, A. K.</creator><creator>Jain, G. K.</creator><general>John Wiley &amp; Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201011</creationdate><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><author>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>antithrombitic</topic><topic>Carbolines - blood</topic><topic>Carbolines - pharmacokinetics</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Fibrinolytic Agents - blood</topic><topic>Fibrinolytic Agents - pharmacokinetics</topic><topic>LC-MS/MS</topic><topic>Male</topic><topic>pharmacokinetics</topic><topic>preclinical</topic><topic>Rabbits</topic><topic>Sulfonamides - blood</topic><topic>Sulfonamides - pharmacokinetics</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhatta, R. S.</creatorcontrib><creatorcontrib>Kumar, D.</creatorcontrib><creatorcontrib>Chhonker, Y. S.</creatorcontrib><creatorcontrib>Saxena, A. K.</creatorcontrib><creatorcontrib>Jain, G. K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhatta, R. S.</au><au>Kumar, D.</au><au>Chhonker, Y. S.</au><au>Saxena, A. K.</au><au>Jain, G. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2010-11</date><risdate>2010</risdate><volume>24</volume><issue>11</issue><spage>1234</spage><epage>1239</epage><pages>1234-1239</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>20954216</pmid><doi>10.1002/bmc.1433</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2010-11, Vol.24 (11), p.1234-1239
issn 0269-3879
1099-0801
language eng
recordid cdi_proquest_miscellaneous_759134789
source Wiley
subjects Animals
antithrombitic
Carbolines - blood
Carbolines - pharmacokinetics
Chromatography, High Pressure Liquid - methods
Fibrinolytic Agents - blood
Fibrinolytic Agents - pharmacokinetics
LC-MS/MS
Male
pharmacokinetics
preclinical
Rabbits
Sulfonamides - blood
Sulfonamides - pharmacokinetics
Tandem Mass Spectrometry - methods
title Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioanalytical%20method%20development%20and%20validation%20of%20novel%20antithrombotic%20agent%20S002-333%20by%20LC-MS/MS%20and%20its%20application%20to%20pharmacokinetic%20studies&rft.jtitle=Biomedical%20chromatography&rft.au=Bhatta,%20R.%20S.&rft.date=2010-11&rft.volume=24&rft.issue=11&rft.spage=1234&rft.epage=1239&rft.pages=1234-1239&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.1433&rft_dat=%3Cproquest_cross%3E1399903096%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1399903096&rft_id=info:pmid/20954216&rfr_iscdi=true